---
schema_version: "secwatch.filing_event.v1"
accession: "0001479681-25-000058"
form_type: "8-K"
ticker: "NUTX"
cik: "0001479681"
company_name: "Nutex Health Inc."
filed_at: "2025-08-14T23:59:59+00:00"
generated_at: "2026-05-17T13:06:03.359506+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Nutex Health reports Q2 prelim revenue $244M (+221% YoY); announces $25M buyback, delays 10-Q

## Summary
- Q2 2025 total revenue $244.0M, up 220.7% from $76.1M in Q2 2024; gross profit $124.9M (51.2% margin) vs $22.6M (29.7%).
- Hospital visits 45,573 (+10.6% YoY); mature hospital visits up 0.6%.
- Delays 10-Q filing due to non-cash accounting adjustments for stock-based compensation on under-construction hospitals; expects to file within 5-day grace period.
- Board authorizes stock repurchase program of up to $25.0M over six months, to commence after 10-Q filing, to offset dilution from stock compensation.
- Cancels previously scheduled August 15 conference call; will reschedule.

## SEC filing metadata
- accession: 0001479681-25-000058
- form_type: 8-K
- ticker: NUTX
- cik: 0001479681
- company_name: Nutex Health Inc.
- filed_at: 2025-08-14T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1479681/000147968125000058/0001479681-25-000058-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1479681/000147968125000058/nutx-20250814.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001479681-25-000058
- JSON: https://secwatch.observer/filing/0001479681-25-000058.json
- Plain text: https://secwatch.observer/filing/0001479681-25-000058.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.